Back
Bolt Biotherapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
40
BOLT
Bolt Biotherapeutics
Last Price:
0.64
Seasonality Move:
-18.53%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing slight buying pressure.
Bolt Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Sell |
| 20-day SMA: | 0.65 | Sell |
| 50-day SMA: | 0.64 | Buy |
| 200-day SMA: | 0.88 | Sell |
| 8-day EMA: | 0.65 | Sell |
| 20-day EMA: | 0.65 | Sell |
| 50-day EMA: | 0.66 | Sell |
| 200-day EMA: | 0.84 | Sell |
Bolt Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 49.57 | Sell |
| Chaikin Money Flow: | -11606 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.64 - 0.66) | Sell |
| Bollinger Bands (100): | (0.63 - 0.73) | Sell |
Bolt Biotherapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bolt Biotherapeutics Stock
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 0.65 while BOLT 8-day simple moving average is 0.65, which is a Sell signal.
- The stock price of BOLT is 0.65 while Bolt Biotherapeutics 20-day SMA is 0.65, which makes it a Sell.
- Bolt Biotherapeutics 50-day simple moving average is 0.64 while BOLT share price is 0.65, making it a Buy technically.
- BOLT stock price is 0.65 and Bolt Biotherapeutics 200-day simple moving average is 0.88, creating a Sell signal.
BOLT Technical Analysis vs Fundamental Analysis
Sell
40
Bolt Biotherapeutics (BOLT)
is a Sell
Is Bolt Biotherapeutics a Buy or a Sell?
-
Bolt Biotherapeutics stock is rated a Sell
The current Bolt Biotherapeutics [BOLT] share price is $0.65. The Score for BOLT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Bolt Biotherapeutics Stock Info
Market Cap:
24.84M
Price in USD:
0.65
Share Volume:
116.06K
Bolt Biotherapeutics 52-Week Range
52-Week High:
1.56
52-Week Low:
0.55
Sell
40
Bolt Biotherapeutics (BOLT)
is a Sell
Bolt Biotherapeutics Share Price Forecast
-
What is the Bolt Biotherapeutics stock price today?
The Bolt Biotherapeutics stock price is 0.65 USD today. -
Will BOLT stock go up or go down?
Bolt Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Bolt Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bolt Biotherapeutics is overvalued.
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 0.65 while BOLT 8-day exponential moving average is 0.65, which is a Sell signal.
- The stock price of BOLT is 0.65 while Bolt Biotherapeutics 20-day EMA is 0.65, which makes it a Sell.
- Bolt Biotherapeutics 50-day exponential moving average is 0.66 while BOLT share price is 0.65, making it a Sell technically.
- BOLT stock price is 0.65 and Bolt Biotherapeutics 200-day simple moving average is 0.84, creating a Sell signal.
Fundamental Analysis of Bolt Biotherapeutics
Is Bolt Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.63 per share.
Technical Analysis of Bolt Biotherapeutics
Should I short Bolt Biotherapeutics stock?
- BOLT Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Bolt Biotherapeutics is a Buy
- Bolt Biotherapeutics Relative Strength Index (RSI) is 49.57, which suggest Bolt Biotherapeutics is oversold
- The Bollinger Bands (25) for Bolt Biotherapeutics is (0.64 - 0.66), which suggest Bolt Biotherapeutics is a Sell
- The Bollinger Bands (100) for Bolt Biotherapeutics is (0.63 - 0.73), which suggest Bolt Biotherapeutics is a Sell
* Bolt Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.